Profil
Irwin Griffith is the founder of IMBiotechnologies Ltd.
He previously worked as the VP-Drug Development-Infectious Diseases at ViRexx Medical Corp.
from 2004 to 2008.
Aktive Positionen von Irwin Griffith
Unternehmen | Position | Beginn |
---|---|---|
IMBiotechnologies Ltd.
IMBiotechnologies Ltd. Medical SpecialtiesHealth Technology IMBiotechnologies Ltd. operates as a medical device company. It develops, manufactures and supplies microspheres and medical devices. The company was founded by Michael Stewart and Irwin Griffith and is headquartered in Edmonton, Canada. | Gründer | 01.08.2009 |
Ehemalige bekannte Positionen von Irwin Griffith
Unternehmen | Position | Ende |
---|---|---|
ViRexx Medical Corp.
ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada. | Corporate Officer/Principal | 01.09.2008 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
ViRexx Medical Corp.
ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada. | Health Technology |
IMBiotechnologies Ltd.
IMBiotechnologies Ltd. Medical SpecialtiesHealth Technology IMBiotechnologies Ltd. operates as a medical device company. It develops, manufactures and supplies microspheres and medical devices. The company was founded by Michael Stewart and Irwin Griffith and is headquartered in Edmonton, Canada. | Health Technology |